Nezam Afdhal Net Worth & Insider Trades
Nezam Afdhal - Chief Medical Officer, Spring Bank Pharmaceuticals, Inc
What is Nezam Afdhal's Net Worth?
The current estimated net worth of Spring Bank Pharmaceuticals, Inc's Chief Medical Officer, Nezam Afdhal, is estimated to be about $450.06K . Nezam Afdhal owns about 40,150 units of Spring Bank Pharmaceuticals, Inc common stock. In the last 3 years at Spring Bank Pharmaceuticals, Inc, Nezam Afdhal has sold an estimated value of $0 worth.
What is Nezam Afdhal's Past Insider Trading?
Nezam Afdhal's largest purchase order was 2,400 units , worth over $30K on September 12, 2016. In total, Nezam Afdhal has made about 9 transactions over 3 years of their time at Spring Bank Pharmaceuticals, Inc. Nezam Afdhal usually trades in August, with the busiest year in 2016.
Nezam Afdhal
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Nezam Afdhal's' Mailing Address?
- Mailing address is C/o Spring Bank Pharmaceuticals, Inc. 113 Cedar Street, Suite S-7 Milford MA 01757 MA
What are Spring Bank Pharmaceuticals, Inc's Past Insider Trades?
Spring Bank Pharmaceuticals, Inc's most recent insider trade came on November 23, 2020 by Garrett Winslow who sold 175 units worth $833 . In the last 4 years, insiders at Spring Bank Pharmaceuticals, Inc have sold an estimated value of $53.87K and bought an estimated value of $4.28M worth of shares. Insider trading is most common in July, with the busiest year in 2016. The most active traders at the company are Martin Driscoll, President and CEO, Kurt Eichler, Director, and Todd Brady, Director .
F-star Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||